Bath & Body Works’ (BBWI) “Outperform” Rating Reiterated at Telsey Advisory Group

Telsey Advisory Group reaffirmed their outperform rating on shares of Bath & Body Works (NYSE:BBWI) in a research note issued to investors on Monday morning, Marketbeat Ratings reports. They currently have a $42.00 target price on the stock. Telsey Advisory Group also issued estimates for Bath & Body Works’ Q4 2025 earnings at $2.07 EPS, FY2025 earnings at $3.28 EPS, Q2 2026 earnings at $0.45 EPS and Q3 2026 earnings at $0.59 EPS.

A number of other brokerages have also recently commented on BBWI. Evercore ISI reduced their target price on shares of Bath & Body Works from $45.00 to $35.00 and set an “in-line” rating for the company in a report on Wednesday, August 28th. Wells Fargo & Company reduced their target price on shares of Bath & Body Works from $35.00 to $32.00 and set an “equal weight” rating for the company in a report on Wednesday, November 6th. Raymond James reduced their target price on shares of Bath & Body Works from $51.00 to $42.00 and set an “outperform” rating for the company in a report on Thursday, August 29th. Citigroup reduced their target price on shares of Bath & Body Works from $48.00 to $35.00 and set a “neutral” rating for the company in a report on Tuesday, August 20th. Finally, Deutsche Bank Aktiengesellschaft reduced their target price on shares of Bath & Body Works from $57.00 to $54.00 and set a “buy” rating for the company in a report on Monday, August 26th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and nine have assigned a buy rating to the company’s stock. According to MarketBeat.com, Bath & Body Works has a consensus rating of “Moderate Buy” and an average target price of $41.88.

Bath & Body Works Trading Up 1.9 %

Shares of BBWI stock opened at $35.90 on Monday. Bath & Body Works has a 12 month low of $26.20 and a 12 month high of $52.99. The company has a market cap of $7.87 billion, a P/E ratio of 8.76, a PEG ratio of 1.14 and a beta of 1.79. The firm has a fifty day moving average price of $30.93 and a 200 day moving average price of $35.65.

Bath & Body Works (NYSE:BBWI) last announced its quarterly earnings results on Wednesday, August 28th. The company reported $0.37 earnings per share for the quarter, beating analysts’ consensus estimates of $0.35 by $0.02. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The firm had revenue of $1.53 billion during the quarter, compared to analysts’ expectations of $1.54 billion. On average, equities analysts forecast that Bath & Body Works will post 3.18 EPS for the current year.

Bath & Body Works Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, December 6th. Shareholders of record on Friday, November 22nd will be given a dividend of $0.20 per share. The ex-dividend date is Friday, November 22nd. This represents a $0.80 annualized dividend and a yield of 2.23%. Bath & Body Works’s payout ratio is currently 19.51%.

Insiders Place Their Bets

In related news, CEO Gina Boswell bought 6,000 shares of the stock in a transaction on Wednesday, October 9th. The shares were bought at an average cost of $29.64 per share, for a total transaction of $177,840.00. Following the completion of the transaction, the chief executive officer now owns 242,987 shares of the company’s stock, valued at $7,202,134.68. This represents a 2.53 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.27% of the stock is currently owned by company insiders.

Institutional Trading of Bath & Body Works

Several large investors have recently modified their holdings of the business. Franklin Resources Inc. grew its position in shares of Bath & Body Works by 50.8% in the third quarter. Franklin Resources Inc. now owns 265,221 shares of the company’s stock valued at $8,230,000 after purchasing an additional 89,350 shares during the last quarter. Wilmington Savings Fund Society FSB purchased a new position in Bath & Body Works during the third quarter worth approximately $39,000. Bard Financial Services Inc. purchased a new position in Bath & Body Works during the third quarter worth approximately $412,000. TD Private Client Wealth LLC raised its stake in shares of Bath & Body Works by 24.2% in the 3rd quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company’s stock valued at $54,000 after acquiring an additional 331 shares during the period. Finally, Nomura Asset Management Co. Ltd. raised its stake in shares of Bath & Body Works by 30.6% in the 3rd quarter. Nomura Asset Management Co. Ltd. now owns 137,610 shares of the company’s stock valued at $4,393,000 after acquiring an additional 32,233 shares during the period. 95.14% of the stock is currently owned by institutional investors and hedge funds.

About Bath & Body Works

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.